Short answer · Medically reviewed summary · Last updated: 2026-05-08
TL;DR: Treatment for Reactive Arthritis focuses on managing inflammation and addressing the underlying trigger infection, typically through nonsteroidal anti-inflammatory drugs (NSAIDs) and, if necessary, disease-modifying antirheumatic drugs (DMARDs). Because Reactive Arthritis affects everyone differently, management must be highly personalized to the specific joints involved and the severity of the systemic symptoms. What are the first-line medical treatments for Reactive Arthritis? The primary goal in treating Reactive Arthritis is to relieve pain and reduce joint inflammation.
TL;DR: Treatment for Reactive Arthritis focuses on managing inflammation and addressing the underlying trigger infection, typically through nonsteroidal anti-inflammatory drugs (NSAIDs) and, if necessary, disease-modifying antirheumatic drugs (DMARDs). Because Reactive Arthritis affects everyone differently, management must be highly personalized to the specific joints involved and the severity of the systemic symptoms.
The primary goal in treating Reactive Arthritis is to relieve pain and reduce joint inflammation. First-line therapy usually involves NSAIDs, such as naproxen (Aleve) or indomethacin (Indocin). If symptoms persist, clinicians may use intra-articular corticosteroid injections to target specific inflamed joints. In cases where Reactive Arthritis becomes chronic or severe, doctors may prescribe conventional DMARDs like sulfasalazine (Azulfidine) or methotrexate (Trexall) to modulate the immune response.
Non-pharmacological interventions are essential for maintaining mobility and preventing long-term joint damage. These include:
The prognosis for Reactive Arthritis is variable; while many patients experience a self-limiting course that resolves within 3 to 6 months, approximately 15% to 20% of individuals develop chronic, recurrent symptoms. Effectiveness depends heavily on the specific pathogen that triggered the condition—often a gastrointestinal or genitourinary infection—and the patient's individual genetic predisposition, such as the presence of the HLA-B27 gene.
Managing Reactive Arthritis often requires a multidisciplinary approach. Your core care team should ideally include a rheumatologist to manage systemic inflammation and, depending on the presentation, an infectious disease specialist, a physical therapist, or an ophthalmologist if eye inflammation occurs. With 33 members currently in the DiseaseMaps community sharing their experiences, connecting with others can provide valuable insights into navigating these specialist relationships.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice; please consult your physician for diagnosis and treatment decisions specific to your health.